More than 17 years of Type 2 disease doubles the odds of a first heart attack….
Read More »Yearly Archives: 2011
Revised Hyperglycemia Levels Predict Retinopathy in Diabetic Patients
“It is proposed that, thresholds of 108 mg/dL for FPG and concentration of 6% for [HbA1c] level could be used to define those who are at risk of retinopathy,” study researchers said….
Read More »Understanding Shared Medical Appointments, Part 1
An Introduction to Group Visits The complex needs of today’s patients present a challenge to medical group physicians who try to meet patients’ needs within the constraints of the traditional office visit. Studies show that the median length of a patient’s face-to-face time during an office visit with a primary …
Read More »Editor’s Note: New Series on SMA’s, Unexpected Side-Effects and More
According to almost every clinician I talk to, it is becoming harder and harder to have enough time with our patients and get reimbursed for it. This is especially true for diabetes patients and is bound to get worse as patients only want to come one time to get help …
Read More »Cost-Effectiveness Strategies, Part 1 of 4
Evaluation of the Kaiser Permanente Northern California population indicated that patients with diabetes are also very likely to have both dyslipidemia and hypertension….
Read More »Letter from the Editor: New Drugs Should Help Our Patients Face Diabetes’ Challenges
Are we starting to pay more attention to the challenges our diabetes patients face each and every day? This week Novo released a study showing the value of their three times a week insulin and how it compares favorably to once a day dosing (Item #7, Study Finds Three Times-a-Week …
Read More »OraMoist™
OraMoist is a breakthrough dry mouth patch that has been specially developed to alleviate parched, dry mouth, lock in moisture for hours, and restore a healthy oral environment. OraMoist is a small, tablet sized dry mouth moisturizer patch that adheres to the roof of the mouth or the inner cheek. …
Read More »Amylin & Takeda suspended the study of pramlintide/metreleptin for obesity
Amylin Pharmaceuticals and Takeda Pharmaceutical announced that they have suspended clinical activities in an ongoing Phase 2 study examining the safety and effectiveness of the investigational combination therapy pramlintide/metreleptin for the treatment of obesity. The clinical study was voluntarily halted to investigate a new antibody-related laboratory finding with metreleptin treatment …
Read More »What Is the Diabetes Belt?
The Southeastern US has been dubbed the “diabetes belt” with 644 mostly southern counties presenting above average rates of diabetes, according to new research by the CDC. There are more than 18 million diabetes sufferers nationwide, with a state pattern emerging for overall averages that matches known risk factors like …
Read More »Coffee May Lower Stroke Risk for Women
Women who drink more than one cup of coffee a day could reduce their risk of stroke by 22% to 25%. A new study followed 34,670 Swedish women, ages 49 to 83, for an average of 10.4 years. Women who reported drinking little or no coffee had a higher risk …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.